ArticleJournal of thoracic disease2025

Predictive factors for the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: a retrospective study.

Yan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.